Amit Mitra

14PUBLICATIONS
91CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 12, 2026
Pan-RAS Inhibitors: Expanding Therapeutic Potential and Evading Resistance.

|Mar 12, 2026
Inhibition of BIRC5 and MCL-1 as a potential treatment strategy to overcome drug resistance in Mantle Cell Lymphoma.

Jeremiah Pfitzer, Sayak Chakravarti, Suman Mazumder

|Nov 27, 2025
Clofazimine Treatment Modulates Key Non-Coding RNAs Associated with Tumor Progression and Drug Resistance in Lethal Prostate Cancer.

Sarah Batten, Harish Kumar, Jeremiah Pfitzer

|Dec 19, 2024
A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer.

Jeremy B Foote, Tyler E Mattox, Adam B Keeton

|Oct 14, 2024
Functional variant rs9344 at 11q13.3 regulates CCND1 expression in multiple myeloma with t(11;14).

Hongwei Tang, Huihuang Yan, Suganti Shivaram

|Dec 06, 2023
Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma.

Amit Kumar Mitra, Ujjal Kumar Mukherjee, Suman Mazumder

Pageof 3

Frequent Collaborators

5 joint publications

Shaji Kumar

4 joint publications

Robert D Arnold

3 joint publications

Neeraj Sharma

3 joint publications

Brian Van Ness